Transce3nd’s Sanofi SNY Stock Holding History

Transce3nd’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-159	Closed	-$7.68K	–	982
2025 Q2	$7.68K	Hold	159	–	–	﹤0.01%	639
2025 Q1	$8.82K	Hold	159	–	–	﹤0.01%	587
2024 Q4	$7.67K	Buy	+159	New	+$8.08K	﹤0.01%	819

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Transce3nd's SNY Position: Q3 2025 in Review

Transce3nd sold out of Sanofi (SNY) in Q3 2025, closing a stake of 159 shares — an estimated $7.68K sold.

Transce3nd first reported a position in SNY in Q4 2024 and held it in 3 quarters. The position peaked at $8.82K in Q1 2025. 712 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

Transce3nd reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 159 Sanofi shares in Q3 2025, an estimated $7.68K.
Transce3nd first reported a position in Sanofi in Q4 2024 and held it in 3 quarters.
Transce3nd's Sanofi position peaked at $8.82K in Q1 2025.
712 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.